Get the Stockscreener App
3.53
0.00%
0.00
After Hours:
3.53
Outset Medical Inc stock is traded at $3.53, with a volume of 88,581.
It is up +0.00% in the last 24 hours and up +4.75% over the past month.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
See More
Previous Close:
$3.53
Open:
$3.6
24h Volume:
88,581
Relative Volume:
0.12
Market Cap:
$64.64M
Revenue:
$119.48M
Net Income/Loss:
$-81.65M
P/E Ratio:
-0.5187
EPS:
-6.8055
Net Cash Flow:
$-47.13M
1W Performance:
+5.37%
1M Performance:
+4.75%
6M Performance:
-76.00%
1Y Performance:
-69.75%
1-Day Range:
$3.42
$3.7399
1-Week Range:
$3.2619
$3.7399
52-Week Range:
$3.00
$21.98
Outset Medical Inc Stock (OM) Company Profile
Name
Outset Medical Inc
Sector
Industry
Phone
669-231-8200
Address
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
3.53 | 64.64M | 119.48M | -81.65M | -47.13M | -6.8055 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-21-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-08-24 | Initiated | BTIG Research | Buy |
| Apr-05-24 | Upgrade | CL King | Neutral → Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-17-23 | Initiated | CL King | Neutral |
| Nov-11-22 | Initiated | RBC Capital Mkts | Outperform |
| Jul-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-18-21 | Initiated | Cowen | Outperform |
| Apr-19-21 | Initiated | Wells Fargo | Overweight |
| Dec-16-20 | Initiated | Oppenheimer | Perform |
| Oct-12-20 | Initiated | Barclays | Overweight |
| Oct-12-20 | Initiated | BofA Securities | Buy |
| Oct-12-20 | Initiated | Goldman | Buy |
| Oct-12-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-12-20 | Initiated | SVB Leerink | Mkt Perform |
| Oct-12-20 | Initiated | Stifel | Buy |
View All
Outset Medical Inc Stock (OM) Latest News
Resistance Check: What is Outset Medical Incs 5 year growth outlookRecession Risk & Daily Technical Forecast Reports - baoquankhu1.vn
If You Invested $1,000 in Outset Medical, Inc. (OM) - Stock Titan
OM.O Technical Analysis & Stock Price Forecast - Intellectia AI
Outset Medical to detail in-house dialysis rollout and nurse impact at AONL2026 - Traders Union
OM SEC FilingsOutset Medical, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Why Did Outset Medical Stock Tumble Today? - MSN
Outset Medical bets on workflow efficiency gains with Tablo Dialysis during AONL2026 - Traders Union
Analyst sentiment on Outset Medical (OM) remains strong following Q4 results - MSN
Short Interest in Outset Medical, Inc. (NASDAQ:OM) Drops By 13.6% - MarketBeat
Momentum Shift: What is Outset Medical Incs 5 year growth outlookQuarterly Profit Summary & Safe Swing Trade Setups - baoquankhu1.vn
Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Outset Medical (OM) soars 22.2%: Is further upside left in the stock? - MSN
Outset Medical, Inc. $OM Position Lessened by Pura Vida Investments LLC - MarketBeat
Shorts Report: Is Outset Medical Inc in a bullish channelEarnings Recap Report & Real-Time Volume Surge Alerts - baoquankhu1.vn
Outset Medical (OM) insider amends Form 3 to add option holdings - Stock Titan
OM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FDA Clears Outset Medical’s Next-Generation Hemodialysis System - Medical Product Outsourcing
Outset Medical Earnings Call Highlights Margin Turnaround - TipRanks
Outset Medical webinar spotlights Community Health Systems insourced dialysis expansion - Traders Union
Outset Medical (OM) Gets a Buy from Stifel Nicolaus - The Globe and Mail
Outset Medical, Inc. (OM) Stock Analysis: A Potential 211% Upside Sparks Investor Interest - DirectorsTalk Interviews
Aug Retail: What is Outset Medical Incs 5 year growth outlookPortfolio Return Summary & Reliable Entry Point Alerts - baoquankhu1.vn
Does Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect? - MSN
Exit Recap: Can Outset Medical Inc sustain earnings growthForecast Cut & High Yield Stock Recommendations - baoquankhu1.vn
OMOutset Medical, Inc. Latest Stock News & Market Updates - Stock Titan
Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results - Yahoo Finance
Leslie Trigg Sells 3,361 Shares of Outset Medical (NASDAQ:OM) Stock - MarketBeat
Outset Medical general counsel Brottem sells $9,520 in stock - Investing.com
Outset Medical general counsel Brottem sells $9,520 in stock By Investing.com - Investing.com UK
[Form 4] Outset Medical, Inc. Insider Trading Activity - Stock Titan
Outset Medical, Inc. (NASDAQ:OM) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Outset Medical (OM) EVP sells 1,817 shares in RSU tax sell-to-cover - Stock Titan
OM (NASDAQ: OM) Form 144: Proposed sale of 9,319 RSU‑settled shares - Stock Titan
Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion - MSN
Outset Medical, Inc. (NASDAQ:OM) Q4 2025 Earnings Call Transcript - Insider Monkey
US$10.50: That's What Analysts Think Outset Medical, Inc. (NASDAQ:OM) Is Worth After Its Latest Results - Yahoo Finance
RBC Capital Reaffirms Their Hold Rating on Outset Medical (OM) - The Globe and Mail
Outset Medical (NASDAQ:OM) Given New $15.00 Price Target at BTIG Research - MarketBeat
Outset Medical, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Stifel lowers price target on Outset Medical, Inc. (OM) to $8, maintains buy rating - MSN
BTIG Lowers Price Target for Outset Medical (OM) to $15, Maintai - GuruFocus
Outset Medical stock dips on Q4 EPS miss - MassDevice
What’s the fair value of Outset Medical Inc. stockJuly 2025 Spike Watch & Verified Swing Trading Watchlists - mfd.ru
Outset Medical Inc (OM) Q4 2025 Earnings Call Highlights: Strate - GuruFocus
Outset Medical: Stabilizing Execution, Improving Margins, and Balanced 2026 Outlook Support Buy Rating Despite Lower Target - TipRanks
Outset Medical Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth By Investing.com - Investing.com Canada
Outset Medical (OM) Sets 2026 Revenue and Margin Targets - GuruFocus
Outset Medical earnings missed by $0.60, revenue fell short of estimates - Investing.com Canada
OM: Revenue up 5% to $119.5M, margin expands, and next-gen Tablo FDA-cleared for 2026 growth - TradingView
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth - Investing.com
Outset Medical Inc Stock (OM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):